Effect of maternal HIV status on breast milk intake and growth of HIV-uninfected Kenyan infants at 6 weeks post-partum and 6 months of age
Not Applicable
Completed
- Conditions
- HIV/AIDS
- Registration Number
- PACTR201807163544658
- Lead Sponsor
- niversity of Nairobi Insitute of Tropical and Infectious Diseases (UNITID)
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 120
Inclusion Criteria
Mother-infants dyads of 6 weeks old HIV-uninfected infants were eligible for this study. The following infants were excluded: infants having <2500g birth weight, preterm infants, infants not able to breastfeed, infants or mothers showing signs of chronic illnesses (as was determined by the project nurse).
Exclusion Criteria
To minimise loss to follow-up, those intending to move away from Siaya District 7-10 months from the date of recruitment into the study were also excluded.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms link maternal HIV status to breast milk intake in HIV-uninfected infants?
How does HIV exposure affect infant growth biomarkers at 6 weeks and 6 months in Kenyan populations?
Are there specific antiretroviral therapies associated with improved breast milk intake in HIV-exposed uninfected infants?
What adverse events are observed in HIV-exposed uninfected infants related to breast milk consumption and maternal HIV status?
How does the PACTR201807163544658 trial compare to other studies on HIV transmission prevention through breastfeeding interventions?